newsfilter
← Latest News
GlobeNewswire·

Professor Dr. Matthias Dobbelstein joins BiondVax's Scientific Advisory Board

Jerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic